Login / Signup

Clinical, trichoscopic, and folliscopic identification of the impact of metabolic syndrome on the response to intradermal dutasteride 0.02% injection in patients with female pattern hair loss: a prospective cohort study.

Nayera MoftahRana MubarakRania Abdelghani
Published in: The Journal of dermatological treatment (2020)
MetS negatively impacted FPHL in terms of response to intradermal injection of dutasteride 0.02% and severity. Further studies are still needed.
Keyphrases
  • metabolic syndrome
  • benign prostatic hyperplasia
  • lower urinary tract symptoms
  • ultrasound guided
  • uric acid
  • case control
  • type diabetes
  • cardiovascular disease
  • cardiovascular risk factors
  • adipose tissue